The U.S. Food and Drug Administration said it will take action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
Colchicine is a highly toxic drug that can easily be administered in excessive doses, especially when given intravenously, the FDA said, noting there's only a narrow margin between an effective dose of the drug and a toxic, perhaps even fatal, dose.
Officials said they had received 50 reports of adverse events associated with the use of intravenous colchicine, including 23 deaths.
"Today's action supports our ongoing efforts to end the marketing of unapproved drugs with serious health risks," said Dr. Janet Woodcock, the FDA's deputy commissioner for scientific and medical programs. "It is a priority that these products be removed from the market."
The FDA warned individuals and companies making the products to cease their activities within 30 days and stop shipping the product within 180 days or face regulatory action. Thereafter, all injectable colchicine drug products must have FDA approval to be manufactured or shipped interstate.
The FDA said its action announced Thursday does not affect colchicine products that are dispensed in tablet form and are frequently used to prevent gout attacks.
Copyright 2008 by United Press International
Related stories:
Vietnam finds tainted products from China
(AP) -- Vietnam's health ministry has discovered the industrial chemical melamine in 18 food products imported from China and three other countries and has ordered them recalled and destroyed, officials said Friday.
FDA: No quick decision on cold medicines for kids
(AP) -- A top government health official rejected the idea of an immediate ban on cough and cold medicines for young children, saying it might cause unintended harm.
Nanodiamond drug device could transform cancer treatment
A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed.
FDA urged to recall cold medicines for youngsters
(AP) -- With a new cold season coming, the government is trying once more to decide what to do about over-the-counter medicines for kids' coughs and sniffles. Doctors question the drugs' benefits and worry about their risks.
Candy with chemical in Chinese milk found in Conn.
(AP) -- An industrial chemical blamed for sickening thousands of infants in China was found in candy in four Connecticut stores this week, a state official said Wednesday.
HIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Now, maraviroc, the first of a new class of HIV drugs called CCR5 receptor antagonists, has been shown to be effective over 48 weeks for drug-resistant patients with R5 HIV-1, a variation of the virus found in more than half of HIV-infected patients.
FDA says changes coming in wake of critical report
(AP) -- The nation's fresh produce would be safer if U.S. farmers were required to adopt strict standards for growing leafy greens similar to industry-written ones devised for California growers, a Food and Drug Administration official said Friday.
Government probes chelation-heart disease study
(AP) -- The largest alternative medicine study the government has ever launched has stopped enrolling people while officials investigate whether participants were fully informed of the risks and are being adequately protected, The Associated Press has learned.